Two Sigma Advisers
TNYA icon

Two Sigma Advisers’s Tenaya Therapeutics TNYA Stock Holding History

Two Sigma Advisers’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-394,500
Closed -$281K – 1963
2025
Q4 		$281K Buy
394,500
+181,000
+85% +$246K ﹤0.01% 2001
2025
Q3 		$346K Buy
213,500
+45,700
+27% +$46K ﹤0.01% 1914
2025
Q2 		$103K Buy
167,800
+116,000
+224% +$59K ﹤0.01% 2206
2025
Q1 		$29.5K Buy
+51,800
New +$51.1K ﹤0.01% 2343
2024
Q4 		– Sell
-76,400
Closed -$147K – 2534
2024
Q3 		$147K Sell
76,400
-3,600
-5% -$10.2K ﹤0.01% 2124
2024
Q2 		$248K Sell
80,000
-34,700
-30% -$143K ﹤0.01% 2144
2024
Q1 		$600K Sell
114,700
-30,300
-21% -$145K ﹤0.01% 1799
2023
Q4 		$470K Sell
145,000
-400
-0.3% -$863 ﹤0.01% 1951
2023
Q3 		$371K Buy
145,400
+86,700
+148% +$363K ﹤0.01% 1905
2023
Q2 		$345K Buy
58,700
+38,400
+189% +$223K ﹤0.01% 1942
2023
Q1 		$57.9K Buy
+20,300
New +$57K ﹤0.01% 2436

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's TNYA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 394,500 shares — an estimated $281K sold.

Two Sigma Advisers first reported a position in TNYA in Q1 2023 and held it in 11 quarters. The position peaked at $600K in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 394,500 Tenaya Therapeutics shares in Q1 2026, an estimated $281K.
  • Two Sigma Advisers first reported a position in Tenaya Therapeutics in Q1 2023 and held it in 11 quarters.
  • Two Sigma Advisers's Tenaya Therapeutics position peaked at $600K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.